Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,771 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical course of liver injury induced by immune checkpoint inhibitors in patients with advanced malignancies.
Ito T, Ishigami M, Yamamoto T, Mizuno K, Yamamoto K, Imai N, Ishizu Y, Honda T, Kawashima H, Yasuda S, Toyoda H, Yokota K, Hase T, Nishio N, Maeda O, Kato M, Hashimoto N, Hibi H, Kodera Y, Sone M, Ando Y, Akiyama M, Shimoyama Y, Fujishiro M. Ito T, et al. Among authors: ando y. Hepatol Int. 2021 Oct;15(5):1278-1287. doi: 10.1007/s12072-021-10238-y. Epub 2021 Aug 9. Hepatol Int. 2021. PMID: 34373964
Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies.
Mizuno K, Ito T, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Kawashima H, Inukai Y, Toyoda H, Yokota K, Hase T, Maeda O, Kiyoi H, Nagino M, Hibi H, Kodera Y, Fujimoto Y, Sone M, Gotoh M, Ando Y, Akiyama M, Hasegawa Y, Fujishiro M. Mizuno K, et al. Among authors: ando y. J Gastroenterol. 2020 Jun;55(6):653-661. doi: 10.1007/s00535-020-01677-9. Epub 2020 Mar 2. J Gastroenterol. 2020. PMID: 32124082
Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis.
Yamamoto T, Mizuno K, Ito T, Yokoyama S, Yamamoto K, Imai N, Ishizu Y, Honda T, Ishikawa T, Kanamori A, Yasuda S, Toyoda H, Yokota K, Hase T, Nishio N, Maeda O, Ishii M, Sone M, Ando Y, Akiyama M, Ishigami M, Kawashima H. Yamamoto T, et al. Among authors: ando y. Invest New Drugs. 2023 Jun;41(3):512-521. doi: 10.1007/s10637-023-01366-3. Epub 2023 May 12. Invest New Drugs. 2023. PMID: 37171720
Obvious Pitfall in the Estimation of Renal Dysfunction.
Shimokata T, Yasuda Y, Ando Y. Shimokata T, et al. Among authors: ando y. J Clin Oncol. 2016 Jul 10;34(20):2429. doi: 10.1200/JCO.2015.65.9243. Epub 2016 May 16. J Clin Oncol. 2016. PMID: 27185841 No abstract available.
Clinical characteristics of gastrointestinal immune-related adverse events of immune checkpoint inhibitors and their association with survival.
Yamada K, Sawada T, Nakamura M, Yamamura T, Maeda K, Ishikawa E, Iida T, Mizutani Y, Kakushima N, Ishikawa T, Furukawa K, Ohno E, Honda T, Kawashima H, Ishigami M, Furune S, Hase T, Yokota K, Maeda O, Hashimoto N, Akiyama M, Ando Y, Fujishiro M. Yamada K, et al. Among authors: ando y. World J Gastroenterol. 2021 Nov 7;27(41):7190-7206. doi: 10.3748/wjg.v27.i41.7190. World J Gastroenterol. 2021. PMID: 34887637 Free PMC article.
Discordance between the results and conclusions of ICON7.
Gyawali B, Shimokata T, Ando Y. Gyawali B, et al. Among authors: ando y. Lancet Oncol. 2015 Oct;16(13):e478. doi: 10.1016/S1470-2045(15)00283-1. Lancet Oncol. 2015. PMID: 26433821 No abstract available.
2,771 results